首页 | 本学科首页   官方微博 | 高级检索  
检索        

复方鳖甲方对博莱霉素致大鼠肺纤维化的防治作用
引用本文:孔璐,王继峰,牛建昭,夏志刚,乔晨,韦燕飞,屠蘅菁.复方鳖甲方对博莱霉素致大鼠肺纤维化的防治作用[J].中国中药杂志,2005,30(3):204-207.
作者姓名:孔璐  王继峰  牛建昭  夏志刚  乔晨  韦燕飞  屠蘅菁
作者单位:北京中医药大学,细胞与生化教研室,北京,100029
基金项目:国家自然科学基金,教育部长江学者和创新团队发展计划
摘    要:目的探讨复方鳖甲方对气管内一次性注入博莱霉素(BLM)诱发大鼠肺纤维化的防治作用及作用机理。方法SD大鼠气管内一次性注入BLM,复制肺纤维化模型,对照组注入生理盐水。中药大、中、小剂量组于造模后第1天灌胃方式给予复方鳖甲方,各组于造模后第7,14,28天腹主动脉抽血4mL,进行动脉血气分析。左肺行组织固定,右肺支气管肺泡灌洗,膜天平法进行肺泡灌洗液表面物质(PS)活性测定。灌洗后右肺液氮速冻,进行羟脯氨酸(HYP)测定。结果7d模型组动物出现明显体重下降、低氧血症、PS系统活性异常,中药中剂量组一定程度上缓解低氧血症(P<005)及PS系统活性。大剂量及小剂量组无明显缓解趋势(P>005)。结论①博莱霉素通过损伤肺泡Ⅱ型细胞(ATⅡ),使PS系统功能异常,从而导致低氧血症的发生,复方鳖甲方中剂量组通过缓解ATⅡ细胞损伤,一定程度上改善低氧血症。②复方鳖甲方有效抑制肺泡灌洗液中的炎性渗出,从而改善肺纤维化程度。

关 键 词:博莱霉素  肺纤维化  复方鳖甲方  肺表面活性物质  动脉血气分析
文章编号:1001-5302(2005)03-0204-04
收稿时间:3/3/2004 12:00:00 AM

The protective effects of Fufang Biejiafang on Bleomycin-induced pulmonary fibrosis in rats
KONG Lu;WANG Ji-feng;NIU Jian-zhao;XIA Zhi-gang;QIAO Chen;WEI Yan-fei;TU Heng-jing.The protective effects of Fufang Biejiafang on Bleomycin-induced pulmonary fibrosis in rats[J].China Journal of Chinese Materia Medica,2005,30(3):204-207.
Authors:KONG Lu;WANG Ji-feng;NIU Jian-zhao;XIA Zhi-gang;QIAO Chen;WEI Yan-fei;TU Heng-jing
Institution:The lab of cell and biochemistry, Beijing University of Chinese Medicine, Beijing 100029, China.
Abstract:OBJECTIVE: To explore the possible effects and mechanism of Fufang Biejiafang on a single intratracheal instillation (IT) of bleomycin-induced lung fibrosis model. METHOD: SD rats were treated with a single IT dose of bleomycin or control saline. Chinese medicine group were poured into the stomach after the first day of operation with high dosage, middle dosage and low dosage. On days 7, 14 and 28 following IT bleomycin or saline, 4 mL blood were taken from the abdominal aorta for arterial blood gas analysis. The left lung was fixed for routine light microscopic examination. Bronchoalveolar lavage fluid (BALF) from the right lung was tested the activity of pulmonary surfactant (PS) by the Whihelmy Film Balance, then the right lung was frozen immediately in liquid nitrogen for determination of hydroxyproline concentration. RESULT: Model rats had obviously changes of body weight and hypoxemia and dysfunction of PS on days 7 and improved on days 14. Compared with three dose groups, the middle dose group some degreely improved and PS function. It ameliorate fibrosis because of inhibition of inflammation. CONCLUSION: (1) PS dysfunction resulted in hypoxemia after bleomycin injured alveolar type II (AT II). Fufang biejiafang-middle dose-group ameliorate hypoxemia by remission AT-II injury. (2) Fufang biejiafang may inhibit exudation inflammation and ameliorate fibrosis.
Keywords:bleomycin  pulmonary fibrosis  Fufang Biejiafang  pulmonary surfactant  analysis of arterial blood gas
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号